Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

14 results
Display

Implications of Persistent Pain in Patients With Rheumatoid Arthritis Despite Remission Status: Data From the KOBIO Registry

Kim HA, Park SY, Shin K

Objective: This study aimed to assess the prevalence of pain in patients with RA in clinical remission and analyze the demographic and clinical characteristics of those who experienced persistent pain...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy

Kim HA, Lee E, Park SY, Lee SS, Shin K

Background: Clinical characteristics and manifestations of psoriatic arthritis (PsA) have been extensively studied in western countries, yet data of Korean patients with PsA are very limited. We aimed to investigate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Use of Disease-modifying Antirheumatic Drugs After Cancer Diagnosis in Rheumatoid Arthritis Patients

Joo YB, Jeong SM, Park YJ, Kim KJ, Park KS

Objective: There is no recommendation for the use of disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) who developed cancer. We examined changes in the DMARDs prescription patterns...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy:a Prospective Single Center Cohort Study

Song YJ, Cho SK, Kim H, Kim HW, Nam E, Bae SC, Yoo DH, Sung YK

Background: Patients with rheumatoid arthritis (RA) undergoing targeted therapy have a higher risk of developing tuberculosis (TB). This requires diagnosis and treatment of latent tuberculosis infection (LTBI). We aimed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Biologic therapies for the treatment of rheumatoid arthritis

Choi SJ

Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the synovial joints. If left untreated, persistent synovial inflammation can lead to cartilage and bone destruction, ultimately causing significant...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus

Park EJ, Kim H, Jung SM, Sung YK, Baek HJ, Lee J

Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inf lammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cost-Minimization Analysis of Biologic Disease-Modifying Antirheumatic Drugs Administered by Subcutaneous Injections in Patients with Rheumatoid Arthritis

Park SH, Lee MY, Lee EK

BACKGROUND: The subcutaneous formulation of biologic disease-modifying antirheumatic drugs (DMARDs) was preferred due to favored self-administration and would be an economical treatment option for patients with rheumatoid arthritis. This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Effectiveness of Biologic DMARDs in Rheumatoid Arthritis Patients with Inadequate Response to conventional DMARDs: Using a Bayesian Network Meta-analysis

Park SK, Kim HL, Lee MY, Kim A, Lee EK

BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) extend the treatment choices for rheumatoid arthritis patients with insufficient response or intolerance to conventional DMARDs (cDMARDs). These agents have considerable efficacy compared with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of juvenile rheumatoid arthritis

Kim KN

The systematic approach to pharmacologic treatment is typically to begin with the safest, simplest, and most conservative measures. It has been realized that the more rapidly inflammation is under control,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rheumatoid Factor is a Marker of Disease Severity in Korean Rheumatoid Arthritis

Shin YS, Choi JH, Nahm DH, Park HS, Cho JH, Suh CH

Serum rheumatoid factor (RF) is important in the diagnosis and prognosis of rheumatoid arthritis (RA). The purpose of this study is to compare the clinical characteristics and treatment patterns of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Disease Modifying Antirheumatic Drugs in Rheumatoid Artritis

Suh CH

  • KMID: 2168064
  • Hanyang Med Rev.
  • 2005 May;25(2):73-79.
Rheumatoid arthritis (RA) is a chronic progressive disease, affecting an estimated 1% of the population worldwide. Although the optimal care of RA patients requires various modalities, pharmacotherapy remains the cornerstone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Paradigm Shifting to Early Treatment of Rheumatoid Arthritis

Park MC, Lee SK

The past decade has greatly enhanced our understanding of rheumatoid arthritis (RA). Not only have new drug therapies become available, but this period has witnessed dramatic changes in treatment strategies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical Therapy for Rheumatoid Arthritis

Min DJ

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovitis and damage of bone and cartilage. The major goals of therapy in RA are to relieve pain, swelling of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medical Treatment of Rheumatoid Arthritis

Lee YH, Song GG

  • KMID: 2015016
  • J Korean Geriatr Soc.
  • 1999 Jun;3(1):7-14.
Rheumatoid arthritis is a chronic inflammatory disease and afflicts approximately 1% of general population. Once considered as a benign non-fatal disease, rheumatoid arthritis is a debilitating condition with a serious...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr